l carnitine tmao nature medicine 2013 koeth γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to Trimethylamine N-Oxide and Related Gut
Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Pay in 4 interest-free payments of $6.73 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13




